Systemic inflammatory response syndrome in patients undergoing transcatheter aortic valve implantation-Reference-Cited by-同舟云学术

Systemic inflammatory response syndrome in patients undergoing transcatheter aortic valve implantation

Published:2023-11 Issue: Volume: Page:
ISSN:1553-8389
Container-title:Cardiovascular Revascularization Medicine
language:en
Short-container-title:Cardiovascular Revascularization Medicine

Author:

Syryca Finn,Pellegrini Costanza,Rheude Tobias,Zobel Florian,Kornhuber Katharina,Xhepa Erion,Mayr N. Patrick,Alvarez-Covarrubias Hector A.,Holdenrieder Stefan,Schunkert Heribert,Thilo Christian,Kastrati Adnan,Joner Michael

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference17 articles.

1. 2021 ESC/EACTS guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS);Vahanian;Eur Heart J,2021

2. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Otto;J Thorac Cardiovasc Surg,2021

3. Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation;Sinning;Eur Heart J,2012

4. Occurrence and prognostic impact of systemic inflammatory response syndrome in transfemoral and transapical aortic valve implantation with balloon- and self-expandable valves;Schwietz;EuroIntervention,2015

5. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine;Bone;Chest,1992